Giant Cell Arteritis which Developed after the Administration of Granulocyte-colony Stimulating Factor for Cyclic Neutropenia

Intern Med. 2016;55(16):2291-4. doi: 10.2169/internalmedicine.55.6704. Epub 2016 Aug 15.

Abstract

A 78-year-old woman diagnosed with cyclic neutropenia 5 years previously had been treated with recombinant granulocyte-colony stimulating factor (G-CSF). She developed fever, tenderness and distension of temporal arteries after the treatment with G-CSF. Magnetic resonance imaging and ultrasonography revealed wall thickening of the temporal arteries. She was therefore diagnosed with giant cell arteritis (GCA). Small vessel vasculitis has been reported as a complication of G-CSF. However, the development of large vessel vasculitis after G-CSF treatment is quite rare. To our knowledge, the present case is the first report of GCA suspected to be associated with coexisting cyclic neutropenia and G-CSF treatment.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Female
  • Giant Cell Arteritis / chemically induced*
  • Giant Cell Arteritis / diagnostic imaging*
  • Giant Cell Arteritis / pathology
  • Granulocyte-Macrophage Colony-Stimulating Factor / administration & dosage
  • Granulocyte-Macrophage Colony-Stimulating Factor / adverse effects*
  • Humans
  • Magnetic Resonance Imaging
  • Neutropenia / drug therapy*

Substances

  • Granulocyte-Macrophage Colony-Stimulating Factor

Supplementary concepts

  • Cyclic neutropenia